| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inhibrx Biosciences, Inc. | Chief Scientific Officer | Common Stock | 434K | $5.61M | $12.93 | 29 May 2024 | By the Eckelman Living Trust Dated February 5, 2014 |
| Inhibrx Biosciences, Inc. | Chief Scientific Officer | Common Stock | 40K | $517K | $12.93 | 29 May 2024 | By trust |
| Inhibrx, Inc. | Chief Scientific Officer | Common Stock | 0 | $0 | $30.00 | 30 May 2024 | By the Eckelman Living Trust dated February 5, 2014 |
| Inhibrx, Inc. | Chief Scientific Officer | Common Stock | 0 | $0 | $30.00 | 30 May 2024 | By trust |
| Inhibrx, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 0 | $0 | $34.12 | 30 May 2024 | Direct |
| Inhibrx Biosciences, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 175K | 30 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| INXB | Inhibrx Biosciences, Inc. | 29 May 2024 | 4 | $0 | 4 | 30 May 2024 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 28 May 2024 | 6 | -$72M | 4 | 30 May 2024 | Chief Scientific Officer |
| INXB | Inhibrx Biosciences, Inc. | 24 May 2024 | 0 | $0 | 3 | 24 May 2024 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 22 May 2024 | 2 | -$171K | 4 | 24 May 2024 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 13 Mar 2024 | 1 | -$67.1K | 4 | 15 Mar 2024 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 08 Mar 2024 | 5 | -$1.4M | 4 | 12 Mar 2024 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 01 Mar 2023 | 2 | -$968K | 4 | 02 Mar 2023 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 01 Feb 2023 | 5 | -$997K | 4 | 02 Feb 2023 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 03 Jan 2023 | 6 | -$949K | 4 | 04 Jan 2023 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 06 Dec 2022 | 3 | -$1.09M | 4 | 07 Dec 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 01 Nov 2022 | 2 | -$1.34M | 4 | 02 Nov 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 04 Oct 2022 | 7 | -$1.11M | 4 | 05 Oct 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 13 Sep 2022 | 3 | $0 | 4 | 14 Sep 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 06 Sep 2022 | 2 | -$596K | 4 | 07 Sep 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 02 Aug 2022 | 2 | -$720K | 4 | 04 Aug 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 07 Jul 2022 | 1 | -$687K | 4 | 08 Jul 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | 05 Apr 2022 | 1 | -$10K | 4 | 07 Apr 2022 | Chief Scientific Officer |